SCHEMBL29654086

SCHEMBL29654086

CCOC(=O)c1ccc2[nH]c(C=O)cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.58
MMP13 P45452 3/20 0.56
MMP2 P08253 2/20 0.56
HCRTR1 O43613 2/20 0.53
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 5/20 0.52
RAB9A P51151 5/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 3/20 0.51
HSD17B10 Q99714 3/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
NPC1 O15118 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
CA12 O43570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28797830 1.00 HRH3 (0.58) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL5793342 0.84 CREBBP (0.48) HRH3ALDH1A1KDM4ERAB9AMEN1
SCHEMBL7920888 0.82 ALDH1A1 (0.68) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL68923 0.81 HRH3 (0.84) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL13061311 0.79 CYP2A6 (0.51) HRH3MMP13MMP2ALDH1A1RAB9A
SCHEMBL16938458 0.79 HRH3 (0.59) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL29654185 0.79 HRH3 (0.59) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL6518479 0.79 HRH3 (0.80) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL27683606 0.78 HRH3 (0.58) HRH3MMP13MMP2HCRTR1ALDH1A1
SCHEMBL27768714 0.78 HRH3 (0.58) HRH3MMP13MMP2HCRTR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109485595-B Hydrophilic group substituted indole formamide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2022-05-27 CN disclosed